Related Experiment Videos
Intracorporeal papaverine injection in androgen deprived men
H W Gilbert1, D A Gillatt, K M Desai
1Department of Urology, Southmead Hospital, Westbury-on-Trym, Bristol.
Journal of the Royal Society of Medicine
|March 1, 1990
Abstract:
The intracorporeal injection of papaverine (ICP) is now a well recognized therapeutic option in the management of impotence. The current treatment of advanced prostatic carcinoma causes erectile failure. Although intracorporeal papaverine can induce erections in these men, libido is also reduced so that the role of ICP is limited to those men complying with the wishes of a highly motivated partner.